Advertisement

Topics

French Biotech Could Be Taking its Diabetes Drug to Phase III on its own

05:25 EDT 4 May 2017 | Labiotech.eu

Poxel was able to score positive results for its type 2 diabetes drug in a Phase IIb study in Japan, preparing the company to go for a Phase III program. Poxel, one of our top biotechs in Lyon, wants to go all the ...

This awesome article French Biotech Could Be Taking its Diabetes Drug to Phase III on its own appeared first on Labiotech.eu. Be kind and don't copy it without asking ;)

Original Article: French Biotech Could Be Taking its Diabetes Drug to Phase III on its own

NEXT ARTICLE

More From BioPortfolio on "French Biotech Could Be Taking its Diabetes Drug to Phase III on its own"

Quick Search
Advertisement
 

Relevant Topics

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...

Clincial Trials
In a clinical trial or interventional study, participants receive specific interventions according to the research plan or protocol created by the investigators. These interventions may be medical products, such as drugs or devices; procedures; or change...